308 related articles for article (PubMed ID: 29988376)
1. NKG2A Expression Is Not
Mahaweni NM; Ehlers FAI; Sarkar S; Janssen JWH; Tilanus MGJ; Bos GMJ; Wieten L
Front Immunol; 2018; 9():1415. PubMed ID: 29988376
[TBL] [Abstract][Full Text] [Related]
2. Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions.
Mahaweni NM; Bos GMJ; Mitsiades CS; Tilanus MGJ; Wieten L
Cancer Immunol Immunother; 2018 Jun; 67(6):861-872. PubMed ID: 29500635
[TBL] [Abstract][Full Text] [Related]
3. Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A.
Sarkar S; van Gelder M; Noort W; Xu Y; Rouschop KM; Groen R; Schouten HC; Tilanus MG; Germeraad WT; Martens AC; Bos GM; Wieten L
Cancer Immunol Immunother; 2015 Aug; 64(8):951-63. PubMed ID: 25920521
[TBL] [Abstract][Full Text] [Related]
4. Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation.
Rathmann S; Glatzel S; Schönberg K; Uhrberg M; Follo M; Schulz-Huotari C; Kaymer M; Veelken H; Finke J; Fisch P
Biol Blood Marrow Transplant; 2010 Apr; 16(4):469-81. PubMed ID: 20044012
[TBL] [Abstract][Full Text] [Related]
5. Partial break in tolerance of NKG2A
Rathmann S; Keck C; Kreutz C; Weit N; Müller M; Timmer J; Glatzel S; Follo M; Malkovsky M; Werner M; Handgretinger R; Finke J; Fisch P
Bone Marrow Transplant; 2017 Aug; 52(8):1144-1155. PubMed ID: 28481352
[TBL] [Abstract][Full Text] [Related]
6. Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling
Mahaweni NM; Ehlers FAI; Bos GMJ; Wieten L
Front Immunol; 2018; 9():2848. PubMed ID: 30564241
[TBL] [Abstract][Full Text] [Related]
7. Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells.
Bigley AB; Rezvani K; Chew C; Sekine T; Pistillo M; Crucian B; Bollard CM; Simpson RJ
Brain Behav Immun; 2014 Jul; 39():160-71. PubMed ID: 24200514
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors.
Oei VYS; Siernicka M; Graczyk-Jarzynka A; Hoel HJ; Yang W; Palacios D; Almåsbak H; Bajor M; Clement D; Brandt L; Önfelt B; Goodridge J; Winiarska M; Zagozdzon R; Olweus J; Kyte JA; Malmberg KJ
Cancer Immunol Res; 2018 Apr; 6(4):467-480. PubMed ID: 29459477
[TBL] [Abstract][Full Text] [Related]
9. Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self.
Michen S; Frosch J; Füssel M; Schackert G; Momburg F; Temme A
Cytotherapy; 2020 Jul; 22(7):354-368. PubMed ID: 32451262
[TBL] [Abstract][Full Text] [Related]
10. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
11. KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing.
Carlomagno S; Falco M; Bono M; Alicata C; Garbarino L; Mazzocco M; Moretta L; Moretta A; Sivori S
Front Immunol; 2017; 8():581. PubMed ID: 28603523
[TBL] [Abstract][Full Text] [Related]
12. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
[TBL] [Abstract][Full Text] [Related]
13. A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1.
Lisovsky I; Isitman G; Song R; DaFonseca S; Tremblay-McLean A; Lebouché B; Routy JP; Bruneau J; Bernard NF
J Virol; 2015 Oct; 89(19):9909-19. PubMed ID: 26202228
[TBL] [Abstract][Full Text] [Related]
14. HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire.
Lauterbach N; Wieten L; Popeijus HE; Voorter CE; Tilanus MG
Hum Immunol; 2015 Aug; 76(8):578-86. PubMed ID: 26382247
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness.
Segerberg F; Lundtoft C; Reid S; Hjorton K; Leonard D; Nordmark G; Carlsten M; Hagberg N
Front Immunol; 2019; 10():2164. PubMed ID: 31572377
[TBL] [Abstract][Full Text] [Related]
16. Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors.
Varker KA; Terrell CE; Welt M; Suleiman S; Thornton L; Andersen BL; Carson WE
J Surg Res; 2007 May; 139(1):36-44. PubMed ID: 17292412
[TBL] [Abstract][Full Text] [Related]
17. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
[TBL] [Abstract][Full Text] [Related]
18. Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells.
Ruggeri L; Urbani E; André P; Mancusi A; Tosti A; Topini F; Bléry M; Animobono L; Romagné F; Wagtmann N; Velardi A
Haematologica; 2016 May; 101(5):626-33. PubMed ID: 26721894
[TBL] [Abstract][Full Text] [Related]
19. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
20. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
